Arylalkylamine drugs of abuse: an overview of drug discrimination studies (Q33748892)

29 July 2017

1 reference

title

Arylalkylamine drugs of abuse: an overview of drug discrimination studies (English)

1 reference

29 July 2017

Glennon RA

1

1 reference

PubMed ID

10515299

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Pharmacology, Biochemistry and Behavior

29 July 2017

1 reference

29 July 2017

64

1 reference

29 July 2017

2

1 reference

29 July 2017

251-256

1 reference

The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Initial characterization of PMMA as a discriminative stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Investigation of hallucinogenic and related beta-carbolines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Discriminative stimulus properties of d-amphetamine and related compounds in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Discriminative stimulus properties of amphetamine and structurally related phenalkylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Discriminative stimulus properties of (-)ephedrine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

(-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900045-3

7 January 2021

10.1016/S0091-3057(99)00045-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10515299